statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioRestorative Therapies, Inc. (NASDAQ:BRTX - Free Report) - Research analysts at Roth Capital reduced their FY2027 EPS estimates for shares of BioRestorative Therapies in a report issued on...

FY2027 EPS Estimates for BioRestorative Therapies, Inc. (NASDAQ:BRTX) Lowered by Roth Capital

BioRestorative Therapies ( NASDAQ:BRTX ) Full Year 2023 Results Key Financial Results Net loss: US$14.4m (loss narrowed...

BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations

- Company is not offering shares pursuant to the registration statement - MELVILLE, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ( BioRestorative , BRTX or the...

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the fourth...

BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q4 2023

MELVILLE, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ( BioRestorative , BRTX or the Company ) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

BioRestorative Therapies, Inc. (NASDAQ:BRTX - Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 19,900...

BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Up 197.0% in March

MELVILLE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ( BioRestorative or the Company ) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies...

BioRestorative Therapies to Participate in the 36th Annual ROTH Conference

BioRestorative Therapies, Inc. (NASDAQ:BRTX  Free Report)  Investment analysts at Roth Capital lifted their FY2023 EPS estimates for BioRestorative Therapies in a research note issued...

Roth Capital Weighs in on BioRestorative Therapies, Inc.'s FY2023 Earnings (NASDAQ:BRTX)

MELVILLE, NY / ACCESSWIRE / February 14, 2024 / BioRestorative Therapies (NASDAQ:BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease...

BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting

BioRestorative Therapies (BRTX) has released an update to notify the public and investors about a regulation fd disclosure. The information detaile...

BioRestorative Therapies Clarifies Disclosure Liability Limits

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Volume	77,372.00
52-Wk High	$7.13
52-Wk Low	$1.20

BRTX BioRestorative Therapies Inc

About

Feed

News

Fundamentals